» Articles » PMID: 21505166

Restenosis: Delineating the Numerous Causes of Drug-eluting Stent Restenosis

Overview
Date 2011 Apr 21
PMID 21505166
Citations 59
Authors
Affiliations
Soon will be listed here.
Citing Articles

From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent Era.

Spadafora L, Quarta R, Martino G, Romano L, Greco F, Curcio A Curr Cardiol Rep. 2025; 27(1):53.

PMID: 39932602 PMC: 11814036. DOI: 10.1007/s11886-025-02193-z.


RapidBrachyIVBT: A dosimetry software for patient-specific intravascular brachytherapy dose calculations on optical coherence tomography images.

Rahbaran M, Kalinowski J, DeCunha J, Croce K, Bergmark B, Tsui J Med Phys. 2024; 52(2):1256-1267.

PMID: 39561213 PMC: 11788245. DOI: 10.1002/mp.17525.


Intracoronary Brachytherapy for Drug-Eluting Stent Restenosis: Outcomes and Clinical Correlates.

Ho E, Denby K, Cherian S, Ciezki J, Kolar M, Wilkinson D J Soc Cardiovasc Angiogr Interv. 2024; 2(1):100550.

PMID: 39132539 PMC: 11308655. DOI: 10.1016/j.jscai.2022.100550.


Off-Label Use of Peripheral Paclitaxel Drug-Coated Balloons in Management of Recurrent Coronary In-Stent Restenosis.

Madhavan M, Hakemi E, Neeranjun R, Rahim H, Nouri S, Flattery E J Soc Cardiovasc Angiogr Interv. 2024; 3(3Part A):101262.

PMID: 39131776 PMC: 11307773. DOI: 10.1016/j.jscai.2023.101262.


Method for assessing coating uniformity of angioplasty balloons coated with poly(lactic-co-glycolic acid) nanoparticles loaded with quercetin.

Zieschang A, Hoffseth K, Dugas T, Astete C, Boldor D Part Sci Technol. 2024; 42(4):601-611.

PMID: 38966520 PMC: 11221576. DOI: 10.1080/02726351.2023.2269881.